Virbac SACA

Virbac : Declaration of the number of shares and voting rights 0/2023

16 Oct 2023 00:57:09 By Nasdaq GlobeNewswire

Virbac will enter the fast-growing poultry vaccines segment in India

09 Oct 2023 04:18:01 By Nasdaq GlobeNewswire

VIRBAC: MAR Weekly Report_VIRBAC SA_2 to 6 October 2023

09 Oct 2023 00:55:23 By Nasdaq GlobeNewswire

Virbac : Half-yearly financial report 2023

06 Oct 2023 09:00:00 By Nasdaq GlobeNewswire

Virbac : Public release of the Half-Year Financial Report at 30 June 2023.

06 Oct 2023 09:00:00 By Nasdaq GlobeNewswire

VIRBAC: MAR Weekly Report_VIRBAC SA_25 to 29 September 2023

02 Oct 2023 01:04:35 By Nasdaq GlobeNewswire

VIRBAC: current operating income before R&D slightly improving throughout first half of 2023 in percentage of revenue

28 Sep 2023 08:45:00 By Nasdaq GlobeNewswire

MAR Weekly Report_VIRBAC SA_18 to 22 September 2023

25 Sep 2023 02:53:20 By Nasdaq GlobeNewswire

MAR Weekly Report_VIRBAC SA_11 to 15 September 2023

18 Sep 2023 02:17:23 By Nasdaq GlobeNewswire

MAR Report_VIRBAC SA_4 to 8 September 2023

11 Sep 2023 00:43:10 By Nasdaq GlobeNewswire

VIRBAC: MAR Weekly Report_VIRBAC SA_21 to 25 August 2023

06 Sep 2023 02:40:50 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 08/2023

05 Sep 2023 06:10:59 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 07/2023

05 Sep 2023 06:07:06 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 06/2023

05 Sep 2023 06:01:27 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 05/2023

05 Sep 2023 05:56:18 By Nasdaq GlobeNewswire

Virbac : Declaration of the number of shares and voting rights 04/2023

05 Sep 2023 05:39:02 By Nasdaq GlobeNewswire

Virbac launches a share buyback program

22 Aug 2023 09:20:18 By Nasdaq GlobeNewswire

VIRBAC - 2023 half-year results: publication postponed to end of September

22 Aug 2023 08:45:00 By Nasdaq GlobeNewswire

Virbac : Revenue up about 2% during the second quarter and stable at the end of June despite two unfavorable one-off effects throughout the semester

18 Jul 2023 08:45:00 By Nasdaq GlobeNewswire

Repeat: Virbac reassesses its 2023 growth and Adjusted EBIT1 forecasts

17 Jul 2023 01:16:01 By Nasdaq GlobeNewswire